Appleton Partners Inc Vertex Pharmaceuticals Inc Transaction History

Appleton Partners Inc

$1.3 Billion
Q2 2024

A detailed history of Appleton Partners Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Appleton Partners Inc holds 1,804 shares of VRTX stock, worth $844,831. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,804

Previous 1,846 2.28%

Holding current value

$844,831

Previous $772,000 9.59%

% of portfolio

0.07%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$392.81 - $485.53 $16,498 - $20,392	-42 Reduced 2.28%	1,804 $846,000
Q1 2024 Apr 01, 2024	SELL	$407.69 - $446.08 $89,284 - $97,691	-219 Reduced 10.61%	1,846 $772,000
Q4 2023 Jan 02, 2024	SELL	$343.0 - $410.68 $410,228 - $491,173	-1,196 Reduced 36.68%	2,065 $840,000
Q3 2023 Oct 03, 2023	SELL	$338.18 - $362.46 $118,024 - $126,498	-349 Reduced 9.67%	3,261 $1.13 Million
Q2 2023 Jul 10, 2023	SELL	$314.42 - $351.91 $58,482 - $65,455	-186 Reduced 4.9%	3,610 $1.27 Million
Q1 2023 Apr 10, 2023	SELL	$283.23 - $323.1 $364,517 - $415,829	-1,287 Reduced 25.32%	3,796 $1.2 Million
Q4 2022 Jan 19, 2023	SELL	$285.76 - $321.48 $136,307 - $153,345	-477 Reduced 8.58%	5,083 $1.47 Million
Q3 2022 Oct 27, 2022	SELL	$273.83 - $305.53 $66,266 - $73,938	-242 Reduced 4.17%	5,560 $1.61 Million
Q2 2022 Jul 08, 2022	SELL	$234.96 - $292.55 $95,158 - $118,482	-405 Reduced 6.52%	5,802 $1.64 Million
Q1 2022 Apr 05, 2022	SELL	$221.42 - $260.97 $204,813 - $241,397	-925 Reduced 12.97%	6,207 $1.62 Million
Q4 2021 Feb 03, 2022	SELL	$177.01 - $223.45 $265,515 - $335,175	-1,500 Reduced 17.38%	7,132 $1.57 Million
Q3 2021 Oct 14, 2021	SELL	$181.39 - $202.99 $149,646 - $167,466	-825 Reduced 8.72%	8,632 $1.57 Million
Q2 2021 Jul 07, 2021	SELL	$187.49 - $221.1 $209,988 - $247,632	-1,120 Reduced 10.59%	9,457 $1.91 Million
Q1 2021 Apr 19, 2021	SELL	$207.02 - $241.31 $93,366 - $108,830	-451 Reduced 4.09%	10,577 $2.27 Million
Q4 2020 Jan 19, 2021	BUY	$207.01 - $276.09 $60,239 - $80,342	291 Added 2.71%	11,028 $2.61 Million
Q3 2020 Oct 14, 2020	BUY	$255.65 - $303.1 $210,144 - $249,148	822 Added 8.29%	10,737 $2.92 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $141,601 - $185,762	628 Added 6.76%	9,915 $2.88 Million
Q1 2020 May 04, 2020	SELL	$199.77 - $247.81 $10,987 - $13,629	-55 Reduced 0.59%	9,287 $2.21 Million
Q4 2019 Jan 13, 2020	BUY	$166.71 - $223.91 $134,534 - $180,695	807 Added 9.46%	9,342 $2.05 Million
Q3 2019 Nov 04, 2019	BUY	$166.23 - $187.09 $1.42 Million - $1.6 Million	8,535 New	8,535 $1.45 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Account

Appleton Partners Inc Vertex Pharmaceuticals Inc Transaction History